Induction of promyelocytic leukemia zinc �nger protein by mir-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin α3β4

HIGHLIGHTS

• who: Sadan Dahal and colleagues from the Yeungnam University have published the paper: Induction of promyelocytic leukemia zinc ufffdnger protein by miR-200c-3p restores sensitivity to anti-androgen therapy in androgen-refractory prostate cancer and inhibits the cancer progression via down-regulation of integrin u03b13u03b24, in the Journal: (JOURNAL)
• what: This study investigated the genes responsible for ARPC progression and ADT resistance and their regulatory mechanisms. This study demonstrated that miR-200c-3p treatment of ARPC is a promising therapeutic approach to restore the sensitivity to anti-androgen therapy and inhibit tumor growth and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.